Home > A. Molecular pathology > PRKACA
PRKACA
Wednesday 6 July 2016
Pathology
Germline PRKACA amplification leads to Cushing syndrome caused by 3 adrenocortical pathologic phenotypes. (25449630)
Recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. (24578576)
- Fibrolamellar carcinoma has a distinctive morphology and immunophenotype, including cytokeratin 7 and CD68 co-expression.
- Recently, fibrolamellar carcinomas were found to harbor a characteristic somatic gene fusion, DNAJB1-PRKACA.
- FISH for the PRKACA rearrangement is a clinically useful tool to confirm the diagnosis of fibrolamellar carcinoma, with high sensitivity and specificity.
See also
DNAJB1-PRKACA
- DNAJB1
- fibrolamellar hepatocellular carcinoma
- chimeric transcript
DNAJB1
PRKACA
Open references
Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer. 2016. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808818/
Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma. 2015. (24578576) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286414/